Skip to content
  • News
  • Insights
  • Interviews
  • Reports
  • Newsletter
Main Menu
  • News
  • Insights
  • Interviews
  • Reports
  • Newsletter
  • Newsletter

CanadaRX Weekly | August 10 Edition

Health Canada authorizes P-I clinical trial of Mod...

Arisa Smith
August 10, 2026
Read More
  • Deals
  • News

Jamieson Wellness to Be Acquired by Kirin for C$2.5B 

Takeaways:  The acquisition turns Jamieson in...

Arisa Smith
August 10, 2026
Read More
  • News
  • Technology

Health Canada Clears Kardium’s Globe AF System 

Takeaways:  The approval should help Kar...

Arisa Smith
August 7, 2026
Read More
  • Insights
  • Manufacturing

Cell and Gene Therapy Manufacturing: The Industry’s Biggest Bottleneck in Healthcare?

Cell and gene therapies are redefining the future of medicine, offering the possibility of long term remission and even cures for diseases once considered untreatable. Yet despite this scientific prom...

Arisa Smith
February 15, 2026
Read More
  • Insights
  • Technology

Data Is the New Drug: Who Will Control the Future of Healthcare Intelligence?

Healthcare is entering an era where data may become as strategically valuable as the therapies themselves. From clinical trials and wearable devices to electronic health records and genomic sequencing...

Arisa Smith
February 12, 2026
Read More
  • Insights
  • R&D

The Obesity Drug Gold Rush: Healthcare Breakthrough or Market Frenzy? 

The Obesity Drug Gold Rush: Healthcare Breakthrough or Market Frenzy? The global pharmaceutical industry is witnessing an unprecedented surge in demand for obesity therapies, transforming what was onc...

Arisa Smith
February 8, 2026
Read More
  • Insights
  • Regulatory

The Patent Cliff Returns: Can Pharma Outrun Billions in Lost Exclusivity?

The pharmaceutical industry is once again approaching a major patent cliff, with several blockbuster therapies set to lose exclusivity over the next few years. For many companies, these products have ...

Arisa Smith
February 5, 2026
Read More
1...131415

The Pharma Canada is your trusted source for the latest pharmaceutical news, regulatory updates, and industry insights across Canada. We keep healthcare professionals, researchers, and industry leaders informed with accurate, timely, and in-depth coverage of Canada's evolving pharma and life sciences landscape. 

Contact Us

Phone: +1 (289) 778-4900

Email: connect@thepharmacanada.ca

    Social Media

    Facebook10FansLikeX (Twitter)10FollowersFollowInstagram10FollowersFollow

    Copyright The PharmaCanada 2026